Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121470934 | 12147093 | 4 | F | 2016 | 20160724 | 20160304 | 20160729 | EXP | US-GILEAD-2016-0196886 | GILEAD | 49.00 | YR | A | F | Y | 64.40000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121470934 | 12147093 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1500225A | 22081 | 10 | MG | TABLET | QD | |||||
| 121470934 | 12147093 | 2 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 4.25 MG, TID | Y | 0 | 4.25 | MG | TID | ||||||
| 121470934 | 12147093 | 3 | SS | ORENITRAM | TREPROSTINIL | 1 | Oral | 2.75 MG, TID | Y | 0 | 2.75 | MG | TID | ||||||
| 121470934 | 12147093 | 4 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | U | 0 | ||||||||||
| 121470934 | 12147093 | 5 | C | ELIQUIS | APIXABAN | 1 | 0 | ||||||||||||
| 121470934 | 12147093 | 6 | C | ADEMPAS | RIOCIGUAT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121470934 | 12147093 | 1 | Pulmonary arterial hypertension |
| 121470934 | 12147093 | 2 | Pulmonary arterial hypertension |
| 121470934 | 12147093 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121470934 | 12147093 | HO |
| 121470934 | 12147093 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121470934 | 12147093 | Back pain | |
| 121470934 | 12147093 | Bronchitis | |
| 121470934 | 12147093 | Catheterisation cardiac | |
| 121470934 | 12147093 | Chest pain | |
| 121470934 | 12147093 | Cough | |
| 121470934 | 12147093 | Drug dose omission | |
| 121470934 | 12147093 | Dyspnoea | |
| 121470934 | 12147093 | Headache | |
| 121470934 | 12147093 | Malaise | |
| 121470934 | 12147093 | Musculoskeletal pain | |
| 121470934 | 12147093 | Nausea | |
| 121470934 | 12147093 | Neck pain | |
| 121470934 | 12147093 | Ocular discomfort | |
| 121470934 | 12147093 | Sinus congestion | |
| 121470934 | 12147093 | Throat irritation | |
| 121470934 | 12147093 | Transient ischaemic attack | |
| 121470934 | 12147093 | Upper respiratory tract congestion | |
| 121470934 | 12147093 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121470934 | 12147093 | 1 | 20160205 | 0 | ||
| 121470934 | 12147093 | 2 | 20150612 | 0 |